We refer to the Company’s announcement on 21 October 2020 in relation to the Proposed Debt Settlement.
On behalf of the Board, KAF IB wishes to announce that the listing application in relation to the Proposed Debt Settlement has been submitted to Bursa Securities on 19 November 2020.
The vaccine, developed with the University of Oxford, showed an average efficacy of 70% in preventing the coronavirus, according to the company. However, that is an average of two dosing regimens — one involving two full doses at least a month apart that proved to be 62% effective. A second regimen, involving a half dose followed by a full does at least one month later was 90% effective, the company said.
Ditanya sama ada BN akan kekal memberi sokongan kepada Belanjawan 2021 secara bersyarat seperti yang diumumkan sebelum ini, Hishamuddin berkata, itu adalah keputusan parti setakat ini.
Yup.Breakout and thn range bound for days.The bullish trends continue again.Now I have 3 counters on vaccines.Vaccine turns now.Some-more this counter on ASEAN region like Solution.Bintai seem laggard.Espect Bintai to chase and reduce the gap with Solution on price. Jackong22 2 posts Posted by Jackong22 > Nov 27, 2020 12:17 PM | Report Abuse
Michael you mean target price RM1.2- 1.4 for Bintai?
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
bluesgang
30 posts
Posted by bluesgang > 2020-11-23 08:05 | Report Abuse
Need to hold. Generex's vaccine is still at pre-clinical stage